|
Real-time
Euronext Paris
07:09:21 13/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 36.35 EUR | -0.82% |
|
+2.39% | -15.56% |
| 21/09 | Neurones S.A.(ENXTPA:NRO) added to S&P Global BMI Index | CI |
| 10/09 | NEURONES Reaffirms Earnings Guidance for the Full Year of 2026 | CI |
Company Valuation: NEURONES
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 920.3 | 950.8 | 1,062 | 1,067 | 1,047 | 873.8 | - | - |
| Change | - | 3.32% | 11.69% | 0.47% | -1.89% | -16.51% | - | - |
| Enterprise Value (EV) 1 | 655.7 | 679 | 771.5 | 747.4 | 710.1 | 542.7 | 510 | 471.8 |
| Change | - | 3.56% | 13.62% | -3.13% | -4.99% | -23.57% | -6.02% | -7.49% |
| P/E | 24.5x | 21.6x | 21.6x | 20.3x | 20.1x | 15.7x | 14.1x | 12.8x |
| PBR | 2.95x | 2.87x | 3x | 2.82x | 2.62x | 2.11x | 1.99x | 1.86x |
| PEG | - | 1.2x | 1.9x | 3.17x | -21.71x | 1.78x | 1.2x | 1.2x |
| Capitalization / Revenue | 1.59x | 1.43x | 1.43x | 1.32x | 1.22x | 0.95x | 0.9x | 0.86x |
| EV / Revenue | 1.13x | 1.02x | 1.04x | 0.92x | 0.83x | 0.59x | 0.52x | 0.46x |
| EV / EBITDA | 8.6x | 7.59x | 8.33x | 7.82x | 7.46x | 5.27x | 4.49x | 3.81x |
| EV / EBIT | 10.6x | 9.31x | 10.2x | 9.59x | 9.39x | 6.57x | 5.52x | 4.62x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1 | 1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Rate of return | 2.63% | 2.55% | 2.74% | 2.96% | 3.25% | 4.09% | 4.37% | 4.64% |
| EPS 2 | 1.55 | 1.82 | 2.03 | 2.16 | 2.14 | 2.329 | 2.598 | 2.869 |
| Distribution rate | 64.5% | 54.9% | 59.1% | 60.2% | 65.4% | 64.4% | 61.6% | 59.2% |
| Net sales 1 | 579.9 | 665.4 | 741.2 | 810.4 | 857.2 | 917.2 | 972.2 | 1,021 |
| EBITDA 1 | 76.28 | 89.44 | 92.61 | 95.58 | 95.14 | 103 | 113.5 | 123.9 |
| EBIT 1 | 61.6 | 72.9 | 75.9 | 77.9 | 75.6 | 82.55 | 92.36 | 102.1 |
| Net income 1 | 37.7 | 44.3 | 49.4 | 52.5 | 52.1 | 56.77 | 63.33 | 69.95 |
| Net Debt 1 | -264.6 | -271.8 | -290.4 | -319.5 | -336.6 | -331.1 | -363.8 | -402 |
| Reference price 2 | 38.00 | 39.25 | 43.75 | 43.95 | 43.05 | 36.65 | 36.65 | 36.65 |
| Nbr of stocks (in thousands) | 24,218 | 24,224 | 24,272 | 24,274 | 24,313 | 23,842 | - | - |
| Announcement Date | 9/2/22 | 8/2/23 | 6/3/24 | 5/3/25 | 11/3/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.74x | 0.59x | 5.27x | 4.09% | 976M | ||
| 22.35x | 3.65x | 12.77x | 2.98% | 214B | ||
| 22.39x | 4.71x | 11.57x | 0.74% | 193B | ||
| -141.78x | 19.72x | 108.42x | -.--% | 127B | ||
| -605.29x | 43.06x | 176.88x | -.--% | 125B | ||
| 15.96x | 1.74x | 9.12x | 3.01% | 128B | ||
| 13.86x | 2.48x | 9.56x | 5.81% | 80.43B | ||
| 21.38x | 5.59x | 13.73x | 2.64% | 63.43B | ||
| 23.78x | 1.97x | 12.5x | 1.31% | 46.45B | ||
| -15.7x | 7.02x | 11.93x | -.--% | 44.27B | ||
| Average | -62.73x | 9.05x | 37.18x | 2.06% | 102.2B | |
| Weighted average by Cap. | -77.89x | 10.52x | 43.79x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- NRO Stock
- Valuation NEURONES
Select your edition
All financial news and data tailored to specific country editions
















